SCHD Dividend ETF Draws Income Attention

SCHD dividend ETF drew attention after an ex-dividend payout, prompting traders to weigh its higher yield and one-year outperformance versus VYM.

September 25, 2026·2 min read
View all news articles
Flat-vector vault merging with a diversified fund token to illustrate the SCHD dividend ETF trade-off.

KEY TAKEAWAYS

  • SCHD had a one-year return of 27.9% versus VYM's 16.0% as of Sept. 18, 2026.
  • SCHD's trailing dividend yield was 3.1% with a 0.06% expense ratio versus VYM's 2.8% yield and 0.04% fee.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Schwab U.S. Dividend Equity ETF (SCHD) attracted investor interest after going ex-dividend on September 23, 2026, prompting comparisons of its concentrated sector exposures and income profile with lower-cost, more diversified dividend ETFs.

Fund Overview and Distribution

SCHD, managed by Schwab Asset Management, tracks the Dow Jones U.S. Dividend 100 Index and holds about 102 stocks selected using criteria including cash-flow-to-debt, return on equity, dividend yield, and dividend growth. This rules-based screening favors companies with measurable payout metrics.

Its largest holdings are Qualcomm (4.8%), Texas Instruments (4.5%), and Coca-Cola (4.2%). Sector weights tilt toward healthcare (21%), consumer defensive (20.4%), and energy (14%), reflecting the fund’s income profile and relative behavior compared with broader dividend ETFs.

The fund’s trailing dividend yield is 3.1%, and it charges an expense ratio of 0.06%. SCHD had roughly $109.4 billion in assets under management as of September 2026. The combination of a mid-single-digit yield and low fees is central to many investors’ allocation decisions.

A distribution of $0.2665 per share went ex-dividend on September 23 and is payable on September 28. Year-to-date distributions for 2026 total about $0.78 per share, compared with $1.05 per share paid in 2025.

Performance and Peer Comparison

As of September 18, 2026, SCHD’s one-year return was 27.9%, compared with 16.0% for Vanguard High Dividend Yield ETF (VYM). Over a decade from September 20, 2016, to September 18, 2026, SCHD’s adjusted price rose 237.6%, while Vanguard S&P 500 ETF (VOO) increased 320.3%. These adjusted-price figures do not reflect total returns.

VYM carries a lower expense ratio of 0.04%, holds roughly 600 stocks, and has a trailing yield near 2.8%. This frames the trade-off for income investors: SCHD offers higher recent yield and one-year performance, while VYM provides lower fees, broader diversification, and stronger five-year growth.

For dividend-focused investors, the choice is between SCHD’s concentrated, dividend-screened approach with stronger recent returns and VYM’s lower-cost, diversified alternative with different long-term growth and volatility characteristics.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Novo Nordisk Nanexa Deal Advances Injectables

Novo Nordisk Nanexa Deal Advances Injectables

Novo Nordisk Nanexa deal gives Novo access to PharmaShell for long-acting injectable programs and shifts trader focus to cardiometabolic R&D.

Polymarket Lawsuit Escalates in New York

Polymarket Lawsuit Escalates in New York

Polymarket lawsuit alleges unlicensed gambling and seeks injunctions and treble fines, raising regulatory risk and trader scrutiny for prediction markets.

Meta Muse AI Expands With New Features

Meta Muse AI Expands With New Features

Meta Muse AI will add real time voice, avatar, connectors and email and reach Meta's glasses, widening touchpoints that could enable monetization.

Akamai Anthropic Deal Reshapes Cloud Strategy

Akamai Anthropic Deal Reshapes Cloud Strategy

Akamai Anthropic deal is a multi-year cloud services pact with equity-linked warrants and multibillion-dollar capex that could shift investor positioning.

Costco Earnings: Q4 Sales, Membership Fees Up

Costco Earnings: Q4 Sales, Membership Fees Up

Costco earnings showed net sales and membership fees rose in the fiscal fourth quarter on Sept. 24, 2026, and investors awaited management's outlook.

Acadia Remlifanserin Phase 2 Results Narrowly Miss

Acadia Remlifanserin Phase 2 Results Narrowly Miss

Acadia remlifanserin Phase 2 results narrowly missed the primary endpoint; a key secondary was nominally significant and the company will advance 60 mg into Phase 3.